Skip to search.
 FTSE 100 Down 0.97%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
0.66 5 May 20:59
|Pre-Market : 0.47 Down 0.19 (28.77%) 14:07 - Nasdaq Real Time Price
Prev Close:0.66
Open:N/A
Bid:0.51 x 2000
Ask:0.55 x 500
1y Target Est:6.58
Beta:N/A
Next Earnings Date: 9-May-16BIND Earnings announcement
Day's Range:N/A - N/A
52wk Range:0.35 - 6.49
Volume:1,000
Avg Vol (3m):377,773
Market Cap:13.79m
P/E (ttm):N/A
EPS (ttm):-1.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BIND at this time.

Comparison

Symbol% ChgMkt Cap
BIND 0.00%13.79m
PGNX349.73m
BMY118.77b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.65
Quarterly EPS Est (Mar-16) :-0.55
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a biotechnology company, develops novel targeted therapeutics primarily for the treatment of cancer in the United States and Russia. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback